FDA approval represents ‘transformational progress’ in hypertension
Drug Discovery World
MARCH 22, 2024
The US Food and Drug Administration (FDA) has approved Tryvio (aprocitentan) for the treatment of hypertension in combination with other antihypertensive drugs, to lower blood pressure in adult patients who are not adequately controlled on other drugs.
Let's personalize your content